Americhem buys Noble Biomaterials to expand in healthcare and defense
What's the deal? AmerichemDealroom has a profile for this one. Try Dealroom →, a global maker of custom polymer solutions, has acquired Noble BiomaterialsDealroom has a profile for this one. Try Dealroom →, an advanced materials company specialising in antimicrobial and conductivity technologies for soft surfaces. The deal, announced on October 27, 2026, carries an undisclosed price.
What each side brings: Americhem runs nine manufacturing plants and sells worldwide. Scranton-based Noble contributes its IONIC+, X-STATIC, and CIRCUITEX platforms, which deliver odour control, infection prevention, and EMI shielding across apparel, healthcare, and aerospace and defence.
What's the endgame? The acquisition combines Americhem's polymer and fibre formulation platform with Noble's proprietary antimicrobial, odour-control, and conductive-fibre technologies. It deepens Americhem's push into high-value healthcare and defence markets, where it has already invested in new facilities in Suzhou, China.
Why now? Americhem has moved aggressively on growth this year, launching several functional additive platforms and hiring a vice president of mergers and acquisitions in March to accelerate deals.
"This is an exciting step forward for Americhem as we continue to invest in high-growth, high-demand markets," said chief executive officer John Richard.
Noble founder and chief commercial officer Joel Furey said its brands "will benefit from Americhem's global scale and deep knowledge of polymer and fibre applications."
What could go wrong? The companies disclosed no price, so the deal's financial scale and expected impact are hard to assess.
The signal: The deal fits a broader specialty-materials pattern of firms using acquisitions to build higher-value, application-specific portfolios. Sector deal volume rose 7.7% in the first quarter of 2026 from the prior quarter, though it stayed below a year earlier, according to an industry M&A review. Unlike large portfolio-shaping polymer transactions, this looks like a targeted capability and technology addition.
Read more: finance.yahoo.com
Image credit: Generated with Gemini
